Jin Yang Pharmaceutical Co. Ltd Cash Flow Conversion Efficiency

Latest as of June 2026: 0.050x

Jin Yang Pharmaceutical Co. Ltd cash flow conversion efficiency. Based on the latest financial reports, Jin Yang Pharmaceutical Co. Ltd (007370) has a cash flow conversion efficiency ratio of 0.050x as of June 2026. Cash flow conversion efficiency measures how effectively a company's net assets (equity) generate operating cash flow. It is calculated by dividing operating cash flow (₩8.05 Billion ≈ $5.45 Million USD) by net assets (₩162.16 Billion ≈ $109.89 Million USD). A higher ratio indicates that the company is more efficient at using its equity to generate cash flow from its core operations.

Cash Flow Conversion Efficiency of Jin Yang Pharmaceutical Co. Ltd (2014–2025)

Cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. This chart illustrates how Jin Yang Pharmaceutical Co. Ltd's cash flow conversion efficiency has evolved over time, based on yearly financial data. View today's stock price for Jin Yang Pharmaceutical Co. Ltd for real-time trading data and today's change.

Jin Yang Pharmaceutical Co. Ltd Cash Flow Conversion Ratio Explained

Jin Yang Pharmaceutical Co. Ltd cash flow conversion ratio divides operating cash flow by net assets, so a higher ratio means more cash generated from each unit of shareholder equity.

Jin Yang Pharmaceutical Co. Ltd Competitors by Cash Flow Conversion Efficiency

The table below lists competitors of Jin Yang Pharmaceutical Co. Ltd ranked by their cash flow conversion efficiency. Also see how much is Jin Yang Pharmaceutical Co. Ltd worth for the company's overall valuation and market capitalisation.

Company	Cash Flow Conversion Efficiency
Steady Safe TBK PT JK:SAFE	0.359x
NextNRG Inc. NASDAQ:NXXT	0.113x
Tocvan Ventures Corp F:TV3	-0.046x
Impresa - Sociedade Gestora de Participações Sociais S.A LS:IPR	-0.174x
Reckon Ltd AU:RKN	0.538x
Phoenix Materials Co. Ltd KQ:050090	-0.010x
Sharps Technology Inc NASDAQ:STSS	-0.017x
Aarey Drugs & Pharmaceuticals Limited NSE:AAREYDRUGS	0.006x

Annual Cash Flow Conversion Efficiency for Jin Yang Pharmaceutical Co. Ltd (2014–2025)

The table below shows the annual cash flow conversion efficiency of Jin Yang Pharmaceutical Co. Ltd from 2014 to 2025. Review Jin Yang Pharmaceutical Co. Ltd free cash flow generation to assess how much free cash flow the company generates relative to operating cash flow.

Year	Net Assets	Operating Cash Flow	Cash Flow Conversion Efficiency	Change
2025-12-31	₩159.86 Billion ≈ $108.33 Million	₩1.46 Billion ≈ $992.80K	0.009x	-91.41%
2024-12-31	₩119.88 Billion ≈ $81.24 Million	₩12.79 Billion ≈ $8.67 Million	0.107x	+12.02%
2023-12-31	₩89.58 Billion ≈ $60.71 Million	₩8.53 Billion ≈ $5.78 Million	0.095x	-0.78%
2022-12-31	₩77.58 Billion ≈ $52.57 Million	₩7.45 Billion ≈ $5.05 Million	0.096x	+218.24%
2021-12-31	₩65.32 Billion ≈ $44.26 Million	₩1.97 Billion ≈ $1.34 Million	0.030x	-77.63%
2020-12-31	₩46.31 Billion ≈ $31.38 Million	₩6.24 Billion ≈ $4.23 Million	0.135x	-18.33%
2019-12-31	₩43.67 Billion ≈ $29.59 Million	₩7.21 Billion ≈ $4.89 Million	0.165x	+555.78%
2018-12-31	₩42.05 Billion ≈ $28.50 Million	₩1.06 Billion ≈ $717.38K	0.025x	+208.08%
2017-12-31	₩42.38 Billion ≈ $28.72 Million	₩-987.16 Million ≈ $-668.99K	-0.023x	-8399.26%
2016-12-31	₩49.15 Billion ≈ $33.31 Million	₩-13.47 Million ≈ $-9.13K	0.000x	+99.41%
2015-12-31	₩59.18 Billion ≈ $40.10 Million	₩-2.76 Billion ≈ $-1.87 Million	-0.047x	+7.06%
2014-12-31	₩61.48 Billion ≈ $41.66 Million	₩-3.08 Billion ≈ $-2.09 Million	-0.050x	--

About Jin Yang Pharmaceutical Co. Ltd

KQ:007370 Korea Drug Manufacturers - Specialty & Generic

Market Cap

$32.47 Million

₩47.92 Billion KRW

Market Cap Rank

#23288 Global

#1594 in Korea

Share Price

₩3390.00

Change (1 day)

-2.02%

52-Week Range

₩3390.00 - ₩5470.00

All Time High

₩9262.22